Stay updated on Pembrolizumab in Neoplasms Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Neoplasms Clinical Trial page.

Latest updates to the Pembrolizumab in Neoplasms Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page adds new helper sections (How to Read a Study Record, Common Questions, How to Join a Study) to assist users in navigating the study details. It also updates the label 'Intervention / Treatment' to 'Intervention/Treatment' and notes the site revision as v3.6.0.SummaryDifference0.5%

- Check20 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating an update to the site template or rendering.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision: v3.5.4 was added and Revision: v3.5.3 was removed. This reflects a backend release update and does not alter the visible study information.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page’s site/application revision indicator was updated from v3.5.2 to v3.5.3, reflecting a maintenance or release update rather than any change to the underlying study details.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision tag updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check98 days agoChange DetectedSite version updated from v3.4.3 to v3.5.0. No visible changes to the study details, eligibility criteria, or other study content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Neoplasms Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Neoplasms Clinical Trial page.